Creating Learning Objectives
Table 1: Learning objectives
Learning objectives guide developers of education materials to synthesize the intended content and ensure that it resonates with the medical needs of the identified beneficiaries. The first one is ensuring that dialysis patients understand how and when to use phosphorus binders (see Table 1). The rationale behind this SMART learning aim is that more individuals with kidney disease encounter numerous challenges, such as increasing levels of phosphorus in the body. Binders play a useful role in overcoming this issue and helping more patients to record positive health outcomes (Thurlow et al., 2021). The inclusion of such an objective will empower and make it easier for more patients to lead high-quality lives.
The second one is ensuring that dialysis patients engage in and appreciate the importance of physical activities. The rationale behind this aim is that exercises allow the body to develop additional healing powers, reduce complications, and improve its response to medications. A proper understanding of such an objective will help more patients manage their conditions more efficiently. The third one is ensuring that material triggers or empowers the individuals to engage in various evidence-based kidney disease management practices (Nair & Cavanaugh, 2020). The reasoning or rationale for choosing this objective is that every patient intends to record positive health experiences. Such an achievement is possible when the individuals engage in a wide range of activities, including taking medications, going for dialysis, managing stress, and lifestyle changes.
To evaluate such objectives, two unique approaches are practical and applicable. The first one is to adopt the use of a teach-back method. This strategy allows individuals to present summarized versions of their views and knowledge gained from the continued adoption of the learning material. The involved interprofessional team will identify the recorded achievements, gaps, and appropriateness of the tool (PrĂĽfe et al., 2022). The second one would entail the use of open-ended questionnaires to understand the overall comprehension of the material and whether it triggers a paradigm shift in the management of kidney disease. For the third objective, a short test would help learn more about the objective and whether desirable outcomes have been recorded. The emerging insights will guide the professionals to offer additional guidelines to make the material more understandable, applicable, and effective.
Risk Management
“Top 10” Risk Register
Project: Educating Healthcare Providers on Phosphorus Management in Hemodialysis Patients
Organization: [Insert Name]
Student Name: [Insert Name]
Table 2: Risk register
Cost-Benefit Analysis
Project Budget
Environmental
Utilities
Equipment
Personnel
Events
Total Cost (Accumulative) = $6,300+5,440+13,700+217,170+3,005
=$245,615
Cost Benefit Analysis
The identified evidence-based ideas and guidelines to support this project include:
- The total number of patients to be served or supported in 12 months = 100(Approx 1800 hours: 18 hours).
- Health professionals work around 1920 hours per year (48 weeks x 40 hours/week).
- 12 sessions of medical guidance and disease management support lasting 90 minutes = 18 hours/patient.
- Kidney disease management and treatment per patient will cost around $8,000 – $12,000
- Continuous sessions for dialysis aimed at improving patient outcomes are effective (Umeukeje et al., 2018).
- Kidney transplant is costly at over $400,000 per patient (Abdi et al., 2022). Disease management and management of phosphorous levels can help mitigate this cost.
Income Acquired
Total Income: 380,000
Benefits/Year = $380,000-245,615 = $134,385
Summary of Results
The completed cost/benefit analysis reveals that there is a need to pursue this project and allow more patients to receive timely support and empowerment. The investigation is founded on the notion that kidney disease is one of the chronic conditions with huge economic, social, and psychological costs on patients and their respective family members. By promoting the suggested education intervention, it is evident that more patients will record positive health outcomes. They will be in a position to pursue their goals while leading high-quality lives. The elimination of additional complications associated with kidney disease will result in reduced need for kidney transplants (Thurlow et al., 2021). The continued implementation of the education intervention will guide more dialysis patients to maintain their phosphorus levels, take medications in a timely manner, and engage in physical exercises. In the long-term, the number of people in demand of dialysis will reduce significantly.
With improved health outcomes and positive reports from most of the patients, the targeted medical facilities will be in a position to focus on other diseases. This development means that the hospitals will be associated with higher reimbursement rates from CMS (Ananthapavan et al., 2021). With the overall costs of supporting the project being around 245,615 US dollars, it is agreeable that the idea is plausible. The anticipated income for the facility is around 380,000 US dollars. Additionally, this could be contrasted with $400,000 US dollars an individual would require to undergo a kidney transplant. The intervention will allow kidney disease management costs to go below the current rate of around $12,000 per patient. In the next few years, the incurred costs under this intervention program will decrease since more patients will experience improved health outcomes.
References
Abdi, F., Alinia, C., Afshari, A. T., & Yusefzadeh, H. (2022). Cost-benefit analysis of kidney transplant in patients with chronic kidney disease: A case study in Iran. Cost Effectiveness and Resource Allocation, 20(1), 37-45. Web.
Ananthapavan, J., Moodie, M., Milat, A., Veerman, L., Whittaker, E., & Carter, R. (2021). Health Research Policy Systems. A cost-benefit analysis framework for preventive health interventions to aid decision-making in Australian governments, 19(1), 147-169. Web.
Brimah, J. J. (2020). Benefit-cost analysis. Salem Press Encyclopedia.
Nair, D., & Cavanaugh, K. L. (2020). Measuring patient activation as part of kidney disease policy: Are we there yet?Journal of American Society of Nephrology, 31(7), 1435-1443. Web.
PrĂĽfe, J., Pape, L., & Kreuzer, M. (2022). Barriers to the successful health care transition of patients with kidney disease: A mixed-methods study on the perspectives of adult nephrologists. Children, 9(6), 803-812. Web.
Thurlow, J. S., Joshi, M., Yan, G., Norris, K. C., Agodoa, L. Y., Yuan, C. M., & Nee, R. (2021). Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. American Journal of Nephrology, 52(2), 98-107. Web.
Umeukeje, E. M., Mixon, A. S., & Cavanaugh, K. L. (2018). Phosphate-control adherence in hemodialysis patients: Current perspectives. Patient Preference and Adherence, 4(12), 1175-1191. Web.